Modified CX3CR1-positive human T cells into Fractalkine/CX3CL1 expressing tumors: importance of the chemokine gradient

I Siddiqui, M Erreni, Mandy van Brakel, Reno Debets, P Allavena

Research output: Contribution to journal › Article › Academic › peer-review

95 Citations (Scopus)

16 Downloads (Pure)

Original language	Undefined/Unknown
Article number	21
Journal	Journal for ImmunoTherapy of Cancer
Volume	4
DOIs	https://doi.org/10.1186/s40425-016-0125-1
Publication status	Published - 2016

Research programs

@article{34c6e19d002c4b6fa7d83fb4b474e2e6,

title = "Modified CX3CR1-positive human T cells into Fractalkine/CX3CL1 expressing tumors: importance of the chemokine gradient",

author = "I Siddiqui and M Erreni and {van Brakel}, Mandy and Reno Debets and P Allavena",

year = "2016",

doi = "10.1186/s40425-016-0125-1",

language = "Undefined/Unknown",

volume = "4",

journal = "Journal for ImmunoTherapy of Cancer",

issn = "2051-1426",

publisher = "BMJ Publishing Group",

}

TY - JOUR

T1 - Modified CX3CR1-positive human T cells into Fractalkine/CX3CL1 expressing tumors: importance of the chemokine gradient

AU - Siddiqui, I

AU - Erreni, M

AU - van Brakel, Mandy

AU - Debets, Reno

AU - Allavena, P

PY - 2016

Y1 - 2016

U2 - 10.1186/s40425-016-0125-1

DO - 10.1186/s40425-016-0125-1

M3 - Article

C2 - 27096098

SN - 2051-1426

VL - 4

JO - Journal for ImmunoTherapy of Cancer

JF - Journal for ImmunoTherapy of Cancer

M1 - 21

ER -